Second Annual International Neonatal Consortium (INC) Workshop

March 7-8, 2016
FDA Campus, Silver Spring, MD


Critical Path Institute
Center for Drug Evaluation and Research, US Food and Drug Administration


The purpose of this workshop was to assess the progress of INC and to inform additional initiatives in regulatory science for neonates that the consortium may undertake. Regulators from PMDA, EMA, Health Canada and FDA engaged in discussions with international academic experts, interested companies, neonatal nursing organizations, NIH institutes, patient groups, and nonprofit organizations.